LancômeClarifique Pro Solution Brightening & Dark Spot Reducing Serum for Hyperpigmentation

WHAT IT IS:
A concentrated brightening serum that visibly reduces dark spots and post-acne marks while tightening the look of pores.

SKIN TYPE:
Suitable for all skin types and tones, including oily skin, sensitive skin and skin prone to acne. Tested for tolerance under dermatological control.

SKIN CONCERN:
Pores, dark spots, post-acne marks.

WHAT IT DOES:
Formulated with 10% PHA, niacinamide and beech bud extract, Clarifique Pro-Solution is a brightening serum that delivers powerful results over time without being harsh on skin. PHA has a larger molecular structure compared to AHA or BHA, allowing it to gently exfoliate the skin surface to minimize irritation. When PHA is combined with an ingredient like niacinamide, it delivers visible brightening results without the unwanted harshness. After using Clarifique Pro-Solution, women see brighter skin in one week and visibly tighter pores in four weeks. In eight weeks, dark spots and post-acne mark skin discoloration are visibly reduced.

HOW TO USE IT:
Use serum daily in both morning and evening skincare routine after cleansing and toning. Twist the cap to open and push down on the silver button to dispense the formula onto your fingertips. Apply formula to the face until fully absorbed, avoiding the eye area. When applying in the morning, it is always necessary to follow with an SPF to protect the skin from sun damage.

CLINICAL RESULTS:
Consumer self-assessment results:
- 96% agree skin texture looks refined*
- 92% agree skin looks brighter*
- 89% agree skin tone looks more even and pores look tightened*
- 84% agree dark spots and skin discoloration are visibly reduced*

Clinically tested results:
- Post-acne marks are visibly reduced -29.7%**
- Dark spots are visibly reduced -20.3%**
- Pores are visibly reduced -18.7%**
- Skin tone is more even +28.2%**

*Based on self-assessment results in a 10-week consumer study with 64 women.
**Based on a 10-week clinical study with 64 women.